Companies lobby for FCPA overhaul; Pozen sells Treximet rights for $75M;

@FiercePharma: Ranbaxy on verge of settling with FDA for $400M, an Indian paper reports--which means its Lipitor copy might launch. More | Follow @FiercePharma

> A move is afoot to amend or otherwise clarify the U.S. Foreign Corrupt Practices Act, as government investigators continue to probe pharma companies for potential bribery violations. More

> Pozen ($POZN) sold its U.S. royalty rights on the migraine drug Treximet to a Canadian pension fund for $75 million. Story

> Another former executive is suing KV Pharmaceutical ($KV.A): Melissa Hughes, a former VP, claims the drugmaker interfered with her stock options. Report

> Tokyo plaintiffs are appealing a court decision that overturned a damages verdict against AstraZeneca ($AZN) in a case over its cancer drug Iressa's side effects. Article

> Three workers were injured in a reactor explosion at Aurobindo Pharma's active pharmaceutical ingredients facility in Ranastalam, India. News

> A Senate Democrat is raising questions about a no-bid contract for an experimental smallpox vaccine awarded to Siga Technologies. More

> Generics maker SOHM bought Novatrend, which makes raw materials for pharma products in India. News

> The diabetes treatment metformin showed promise in reducing cancer risk, according to a new study. Piece

Biotech News

@FierceBiotech: Activist investor pursues alternative strategies for Par Pharma. News | Follow @FierceBiotech

@RyanMFierce: GE is pumping another $300M into radiation-dose management tech. Release | Follow @RyanMFierce

@MaureenFierce: U.K. switches to Merck's Gardasil for HPV vaccination. Item | Follow @MaureenFierce

> Novartis grabs European approval of combo pill for high blood pressure. Article

> Developer looks to nanoparticles for smoking cessation vaccine. Story

> Who's got a powerful grip in biopharma? More

Medical Device News

> ArthroCare to pay $74M to settle class action. Story

> Fujifilm to begin trial of 3-D digital mammography tech. News

> Philips gets FDA OK for Ingenuity system. Item

> Toshiba showcases imaging systems at RSNA conference. Piece

Biotech IT News

> Roche, BGI team on new capture tech for genetics studie. Article

> GNS Healthcare CEO launches Forbes blog. More

> Mining data on FDA-OK'd drugs leads to potential cancer treatment. News

And Finally... Should off-label marketing fines fund study of off-label uses? More

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.